Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (13)

2023

  1. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    Journal of Infection, Vol. 87, Núm. 1, pp. 46-53

2022

  1. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

    Microbiology Spectrum, Vol. 10, Núm. 3

2021

  1. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group

    Transplant Infectious Disease, Vol. 23, Núm. 4

  2. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study

    Journal of Infection, Vol. 83, Núm. 3, pp. 306-313

  3. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group

    American Journal of Transplantation, Vol. 21, Núm. 1, pp. 258-271

2020

  1. Risk factors and outcome of COVID-19 in patients with hematological malignancies

    Experimental Hematology and Oncology, Vol. 9, Núm. 1

2017

  1. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367

2015

  1. Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: Results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)

    Transplant Infectious Disease, Vol. 17, Núm. 2, pp. 221-233

2013

  1. Tratamiento de las infecciones fúngicas invasoras en pacientes hematológicos de alto riesgo: ¿Qué hemos aprendido en los pasados 10 años?

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 4, pp. 378-386

2011

  1. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

    Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16

2008

  1. Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71

2007

  1. Update on viral infections in immunocompromised patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 2-11

2006

  1. Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients [14]

    Leukemia